DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ advanced 3.22% to $5.45 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.80% to 18,239.92 and the Dow Jones Industrial Average rising 0.69% to 42,052.19.
Inovio Pharmaceuticals Inc. closed $9.30 below its 52-week high ($14.75), which the company achieved on April 1st.
The stock outperformed some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 0.17% to $160.13, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ fell 0.74% to $28.09.
Trading volume (233,505) remained 57,646 below its 50-day average volume of 291,151.
Data source: Dow Jones Market Data, FactSet. Data compiled November 1, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 01, 2024 17:27 ET (21:27 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。